Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Saturday, August 9, 2025

Oxygen Extraction Fraction on Baseline MRI Predicts Infarction Growth in Successfully Reperfused Patients

 WHAT WILL PREVENT INFARCTION GROWTH? WHOM will do the research to solve that? Nothing will occur, we have NO leadership and NO strategy in stroke, so your children and grandchildren will still be screwed when they have strokes!

LEADERS would look at this and say; 'Let's do the research to solve the problem! You're uselessly predicting a problem; NOT SOLVING IT! 

But there are NO FUNCTIONING BRAIN CELLS IN THE STROKE MEDICAL WORLD!

Oxygen Extraction Fraction on Baseline MRI Predicts Infarction Growth in Successfully Reperfused Patients


Asghariahmadabad MD, Ameera MD, Metanat MD, https://orcid.org/0000-0003-2905-4080Tavakkol MD  https://orcid.org/0000-0003-2869-8087, Bahr-Hosseini MD https://orcid.org/0000-0003-3049-4542,  Viktor Szeder MD, PhD https://orcid.org/0000-0003-0703-8258, Geoffrey P. Colby MD, PhD https://orcid.org/0000-0002-3376-0933, Show All … , and Kambiz NaelMD https://orcid.org/0000-0002-4194-9488 kambiznael@gmail.com
Author Info & AffiliationsInformation & Authors
  • Metrics & Citations
  • Get Access
  • References
  • Figures
  • Abstract

    BACKGROUND:
    In patients with acute ischemic stroke, infarct growth occurs despite successful reperfusion. Oxygen extraction fraction (OEF) has shown promising results in evaluating ischemic tissue viability and can now be quantified from routinely performed dynamic susceptibility contrast perfusion. We aimed to determine the association of OEF alterations within the ischemic tissue on pretreatment magnetic resonance imaging and infarct growth in patients who underwent successful reperfusion.

    METHODS:

    In this retrospective cohort study from the University of California, Los Angeles, between 2015 and 2020, patients were included if they had anterior circulation large vessel occlusion, achieved successful reperfusion (Thrombolysis in Cerebral Infarction ≥2b), had pretreatment dynamic susceptibility contrast perfusion and posttreatment magnetic resonance imaging within 48 hours from reperfusion. Dynamic susceptibility contrast-derived OEF values were quantified from the segmented ischemic core (apparent diffusion coefficient ≤620×10−6 mm2/s) and penumbra tissue (time-to-maximum [Tmax] >6 s) on pretreatment magnetic resonance imaging and normalized to contralateral hemisphere (relative oxygen extraction fraction [OEFr]). Primary outcome was substantial infarct growth ≥10 mL, and secondary outcomes were continuous measures of infarct growth volume and penumbra-to-infarct conversion ratio. The associations between baseline clinical and imaging variables, including OEFr and outcome measures, were tested by multivariate and regression analysis.

    RESULTS:

    Among 89 patients who met inclusion criteria, 33 (37%) patients had infarct growth ≥10 mL. Patients with infarct growth had significantly (P<0.0001) lower penumbra-OEFr values compared with those without infarct growth. There was significant association between penumbra OEFr and infarct growth (β=−2.9 [95% CI, −5.0 to −0.8]; P=0.007) and similarly for penumbra-to-infarct conversion ratio (β=−10.4 [95% CI, −19.6 to −1.2]; P=0.028).

    CONCLUSIONS:

    Our results showed penumbra-OEFr is a promising imaging biomarker for predicting infarct growth in acute ischemic stroke following successful reperfusion. Although elevation of penumbra-OEFr is protective, patients with lower penumbra-OEFr values sustained further ischemic injury and infarct growth.

    Graphical Abstract

    Get full access to this article

    View all available purchase options and get full access to this article.

    No comments:

    Post a Comment